Zobrazeno 1 - 1
of 1
pro vyhledávání: '"on, behalf of Saitama Breast Cancer Clinical Study Group (SBCCSG)"'
Autor:
Yuji, Hayashi, Hiroyuki, Takei, Tsuyoshi, Saito, Toshihiro, Kai, Kenichi, Inoue, Masafumi, Kurosumi, Jun, Ninomiya, on, behalf of Saitama Breast Cancer Clinical Study Group (SBCCSG), Hayashi, Yuji, Takei, Hiroyuki, Saito, Tsuyoshi, Kai, Toshihiro, Inoue, Kenichi, Kurosumi, Masafumi, Ninomiya, Jun, behalf of Saitama Breast Cancer Clinical Study Group (SBCCSG), on
Publikováno v:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 88(4)
BACKGROUND Neoadjuvant endocrine therapy is not the standard of care for breast cancer, primarily because the optimal treatment duration remains unclear. This phase 2 prospective multicenter study analyzed time to progression, time to maximal respons